GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
52.64 +0.32  +0.61% NYSE Apr 16, 9:32AM BATS Real time Currency in USD

GlaxoSmithKline Return on Equity (TTM):

85.94% for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Return on Equity (TTM) Chart

Pro Export Data
Pro Save Image

GlaxoSmithKline Historical Return on Equity (TTM) Data

Pro Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 85.94%
Sept. 30, 2013 60.99%
June 30, 2013 61.72%
March 31, 2013 59.94%
Dec. 31, 2012 63.13%
Sept. 30, 2012 65.50%
June 30, 2012 64.37%
March 31, 2012 59.75%
Dec. 31, 2011 62.63%
Sept. 30, 2011 38.16%
June 30, 2011 36.51%
March 31, 2011 20.18%
Dec. 31, 2010 16.93%
Sept. 30, 2010 41.08%
June 30, 2010 43.27%
March 31, 2010 64.20%
Dec. 31, 2009 65.58%
Sept. 30, 2009 58.87%
June 30, 2009 56.63%
March 31, 2009 Go Pro
Dec. 31, 2008 Go Pro
Sept. 30, 2008 Go Pro
June 30, 2008 Go Pro
March 31, 2008 Go Pro
Dec. 31, 2007 Go Pro
   
Sept. 30, 2007 Go Pro
June 30, 2007 Go Pro
March 31, 2007 Go Pro
Dec. 31, 2006 Go Pro
Sept. 30, 2006 Go Pro
June 30, 2006 Go Pro
March 31, 2006 Go Pro
Dec. 31, 2005 Go Pro
Sept. 30, 2005 Go Pro
June 30, 2005 Go Pro
March 31, 2005 Go Pro
Dec. 31, 2004 Go Pro
Sept. 30, 2004 Go Pro
June 30, 2004 Go Pro
March 31, 2004 Go Pro
Dec. 31, 2003 Go Pro
Sept. 30, 2003 Go Pro
June 30, 2003 Go Pro
March 31, 2003 Go Pro
Dec. 31, 2002 Go Pro
Sept. 30, 2002 Go Pro
June 30, 2002 Go Pro
March 31, 2002 Go Pro
Dec. 31, 2001 Go Pro
Sept. 30, 2001 Go Pro

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Get data for
Advertisement

GSK Return on Equity (TTM) Benchmarks

Companies
AstraZeneca 11.04%
Eli Lilly 29.48%
Johnson & Johnson 20.03%

GSK Return on Equity (TTM) Range, Past 5 Years

Minimum 16.93% Dec 2010
Maximum 85.94% Dec 2013
Average 53.97%
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.